Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism: A multicenter comparison of patient-centered outcomes.

Rao G, Xu H, Wang JJ, Galmer A, Giri J, Jaff MR, Kolluri R, Lau JF, Selim S, Weinberg I, Weinberg MD.

Vasc Med. 2019 Jun;24(3):241-247. doi: 10.1177/1358863X19838334. Epub 2019 Mar 27.

PMID:
30915914
2.

A case series of cementless revision total knee arthroplasty in patients with benzoyl peroxide allergy.

Fröschen FS, Gravius N, Lau JF, Randau TM, Kaup E, Friedrich MJ, Gravius S.

Int Orthop. 2018 Dec 11. doi: 10.1007/s00264-018-4273-4. [Epub ahead of print]

PMID:
30539218
3.

[Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer].

Pantelis D, Lingohr P, Hueneburg R, Spier I, Vilz T, Lau JF, Nattermann J, Aretz S, Strassburg CP, Kalff JC.

Zentralbl Chir. 2018 Aug 1. doi: 10.1055/a-0646-4382. [Epub ahead of print] German.

PMID:
30068014
4.

Re-evaluating the Appropriateness of Non-invasive Arterial Vascular Imaging and Diagnostic Modalities.

Misher JM, Galmer AM, Weinberg MW, Pellerito JS, Lau JF.

Curr Treat Options Cardiovasc Med. 2017 Aug;19(8):63. doi: 10.1007/s11936-017-0558-y. Review.

PMID:
28681274
5.

Building a Successful Superficial Venous Program.

Galmer A, Dunn J, Zaric M, Lau JF, Weinberg M.

Curr Treat Options Cardiovasc Med. 2017 Aug;19(8):59. doi: 10.1007/s11936-017-0557-z. Review.

PMID:
28639184
6.

Advanced vascular imaging.

Weinreich M, Litwok Y, Mui LW, Lau JF.

Vasc Med. 2017 Feb;22(1):73-76. doi: 10.1177/1358863X16681666. Review. No abstract available.

PMID:
28215105
7.

Building a Critical Limb Ischemia Program.

Galmer AM, Selim SM, Giri J, Lau JF, Weinberg MD.

Curr Treat Options Cardiovasc Med. 2016 Aug;18(8):50. doi: 10.1007/s11936-016-0476-4. Review.

PMID:
27289583
8.

The vascular laboratory.

Litwok Y, Weinreich M, Lau JF.

Vasc Med. 2016 Aug;21(4):396-9. doi: 10.1177/1358863X16650514. Epub 2016 Jun 8. No abstract available.

PMID:
27278652
9.

Serpentine supravenous hyperpigmentation due to hydroxychloroquine.

Lau JF, Dean SM, Rooke TW, Olin JW.

Vasc Med. 2016 Dec;21(6):558-559. Epub 2016 May 19. No abstract available.

PMID:
27197682
10.

Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1.

Nilsson C, Hansen TK, Rosenquist C, Hartmann B, Kodra JT, Lau JF, Clausen TR, Raun K, Sams A.

Eur J Pharmacol. 2016 Feb 15;773:24-31. doi: 10.1016/j.ejphar.2016.01.003. Epub 2016 Jan 22.

PMID:
26808305
11.

The fluoro-less and contrast-less peripheral endovascular intervention: a concept for the future today.

Ephrem G, Lau JF, Meraj PM.

Cardiovasc Revasc Med. 2015 Jul-Aug;16(5):294-8. doi: 10.1016/j.carrev.2015.05.004. Epub 2015 May 21.

PMID:
26054718
12.

The S curve: a novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia.

Sethi SS, Lau JF, Godbold J, Gustavson S, Olin JW.

Vasc Med. 2014 Oct;19(5):356-62. doi: 10.1177/1358863X14547122. Epub 2014 Aug 18.

PMID:
25135311
13.

Oral anticoagulants in the management of venous thromboembolism.

Makaryus JN, Halperin JL, Lau JF.

Nat Rev Cardiol. 2013 Jul;10(7):397-409. doi: 10.1038/nrcardio.2013.73. Epub 2013 May 21. Review.

PMID:
23689703
14.

Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective α-melanocyte-stimulating hormone (α-MSH) analogues.

Conde-Frieboes K, Thøgersen H, Lau JF, Sensfuss U, Hansen TK, Christensen L, Spetzler J, Olsen HB, Nilsson C, Raun K, Dahl K, Hansen BS, Wulff BS.

J Med Chem. 2012 Mar 8;55(5):1969-77. doi: 10.1021/jm201489a. Epub 2012 Feb 24.

PMID:
22335602
15.

Peripheral artery disease. Part 2: medical and endovascular treatment.

Weinberg MD, Lau JF, Rosenfield K, Olin JW.

Nat Rev Cardiol. 2011 Jun 14;8(8):429-41. doi: 10.1038/nrcardio.2011.81. Review.

PMID:
21670746
16.

Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Lau JF, Weinberg MD, Olin JW.

Nat Rev Cardiol. 2011 May 31;8(7):405-18. doi: 10.1038/nrcardio.2011.66. Review.

PMID:
21629211
17.

Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devices.

Garcia-Alvarez A, Fernandez-Friera L, Lau JF, Sawit ST, Mirelis JG, Castillo JG, Pinney S, Anyanwu AC, Fuster V, Sanz J, Garcia MJ.

J Heart Lung Transplant. 2011 Aug;30(8):896-903. doi: 10.1016/j.healun.2011.03.009. Epub 2011 May 6.

PMID:
21530319
18.

Imaging approaches for the study of cell-based cardiac therapies.

Lau JF, Anderson SA, Adler E, Frank JA.

Nat Rev Cardiol. 2010 Feb;7(2):97-105. doi: 10.1038/nrcardio.2009.227. Epub 2009 Dec 22. Review.

19.

Advanced lipoprotein testing: recommendations based on current evidence.

Lau JF, Smith DA.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):1-31. doi: 10.1016/j.ecl.2008.11.008. Review.

PMID:
19217510
20.

Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.

Lau JF, Jeppesen CB, Rimvall K, Hohlweg R.

Bioorg Med Chem Lett. 2006 Oct 15;16(20):5303-8.

PMID:
16908150
21.

Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor.

Severinsen R, Lau JF, Bondensgaard K, Hansen BS, Begtrup M, Ankersen M.

Bioorg Med Chem Lett. 2004 Jan 19;14(2):317-20.

PMID:
14698149
22.

A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-C and clk-1 mutants.

Taub J, Lau JF, Ma C, Hahn JH, Hoque R, Rothblatt J, Chalfie M.

Nature. 2003 Feb 13;421(6924):764. No abstract available.

PMID:
12610632
23.

A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.

Kraus TA, Lau JF, Parisien JP, Horvath CM.

J Biol Chem. 2003 Apr 11;278(15):13033-8. Epub 2003 Feb 5.

24.

Role of metazoan mediator proteins in interferon-responsive transcription.

Lau JF, Nusinzon I, Burakov D, Freedman LP, Horvath CM.

Mol Cell Biol. 2003 Jan;23(2):620-8.

25.

Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.

Andersen HS, Olsen OH, Iversen LF, Sørensen AL, Mortensen SB, Christensen MS, Branner S, Hansen TK, Lau JF, Jeppesen L, Moran EJ, Su J, Bakir F, Judge L, Shahbaz M, Collins T, Vo T, Newman MJ, Ripka WC, Møller NP.

J Med Chem. 2002 Sep 26;45(20):4443-59.

PMID:
12238924
27.

Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.

Lau JF, Horvath CM.

Mt Sinai J Med. 2002 May;69(3):156-68. Review.

PMID:
12035075
28.
29.

The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM.

Virology. 2001 May 10;283(2):230-9.

31.

Supplemental Content

Support Center